References
- Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149:1731–1741.3.
- Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198–1210.
- Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5:648–661; quiz 644.
- Draganov P, Forsmark CE. "Idiopathic" pancreatitis. Gastroenterology. 2005;128:756–763.
- Fathallah N, Slim R, Larif S, et al. Drug-induced acute pancreatitis confirmed by positive re-challenge. Pancreat Disord Ther. 2015;S6.
- Jones JK. Determining causation from case reports. In: Pharmacoepidemiology. New York, NY: John Wiley & Sons; 2007. p. 555–570.
- Schiffer B, Daxenberger A, Meyer K, et al. The fate of trenbolone acetate and melengestrol acetate after application as growth promoters in cattle: environmental studies. Environ Health Perspect. 2001;109:1145–1151.
- McBride JA, Carson CC 3rd, Coward M. The availability and acquisition of illicit anabolic androgenic steroids and testosterone preparations on the Internet. Am J Mens Health. 2016. doi:10.1177/1557988316648704
- Haerinejad MJ, Ostovar A, Farzaneh MR, et al. The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the South of Iran, Bushehr. Asian J Sports Med. 2016;7:e35018.
- Liane BJ, Magee C. Guerilla warfare on the pancreas? A case of acute pancreatitis from a supplement known to contain anabolic-androgenic steroids. Mil Med. 2016;181:e1395–005e1397.
- Rosenfeld GA, Chang A, Poulin M, et al. Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to the recreational use of methandrostenolone: a case report. J Med Case Rep. 2011;5:138.
- Zaki, SA. Adverse drug reaction and causality assessment scales. Lung India: Official organ of Indian Chest Society. PMC 2011;28(2):152–153. (accessed 20 July 2018).
- Forsmark CE, Baillie J, AGA Institute Clinical Practice and Economics Committee, et al. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022–2044.
- Hanck C, Singer MV. Does acute alcoholic pancreatitis exist without preexisting chronic pancreatitis? Scand J Gastroenterol. 1997;32:625–626.
- Dawson RT. Drugs in sport – the role of the physician. J Endocrinol. 2001;170:55–61.
- Rahnema CD, Crosnoe LE, Kim ED. Designer steroids – over-the-counter supplements and their androgenic component: review of an increasing problem. Andrology. 2015;3:150–155.
- Colburn S, Childers WK, Chacon A, et al. The cost of seeking an edge: recurrent renal infarction in setting of recreational use of anabolic steroids. Ann Med Surg (Lond). 2017;14:25–28.
- Sagoe D, Molde H, Andreassen CS, et al. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383–398.
- C G, B C, As A, et al. Study of arrhythmias within 48 hours of acute inferior wall myocardial infarction. J Assoc Phys India. 2016;64:75.
- Snyder P. (2018). Use of androgens and other hormones by athletes. In K.A. Martin (Ed.). UpToDate. Retrieved July 20th, 2018 from https://www.uptodate.com/contents/use-of-androgens-and-other-hormones-by-athletes
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245.
- Gallagher RM, Kirkham JJ, Mason JR, et al. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One. 2011;6:e28096.
- Elliott S, Sedefov R, Evans-Brown M. Assessing the toxicological significance of new psychoactive substances in fatalities. Drug Test Anal. 2018;10:120–126.